Universe Pharmaceuticals INC Research and Development Expense
Universe Pharmaceuticals INC (UPC) reported Research and Development Expense of $671.76 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-01-29
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $671.76M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $3.03B 20-F · filed 2026-01-29 | $3.03M 20-F · filed 2025-04-29 | |
| 2024-03-31 | $86.50K 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $4.86B 20-F · filed 2026-01-29 | $4.86M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $2.27M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $7.64M 20-F · filed 2025-04-29 | ||
| 2022-03-31 | $144.46K 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $5.47M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $310.67K 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $583.13K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $618.44K 20-F · filed 2022-01-31 |